Proteolytic enzymes, cell surface changes, and viral transformation.
D001665:Binding Sites; D002448:Cell Adhesion; D002449:Cell Aggregation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002462:Cell Membrane / Q000032:analysis / Q000378:metabolism / Q000648:ultrastructure; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D006025:Glycosaminoglycans / Q000032:analysis; D037102:Lectins / Q000494:pharmacology; D008954:Models, Biological; D010447:Peptide Hydrolases / Q000096:biosynthesis / Q000494:pharmacology; D010641:Phenotype; D010958:Plasminogen / Q000378:metabolism; D011480:Protease Inhibitors; D011506:Proteins / Q000032:analysis; D013917:Thrombin / Q000378:metabolism; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology; D014361:Trypsin Inhibitors; D014780:Viruses / Q000254:growth & development
D004791:Enzyme Inhibitors; D006025:Glycosaminoglycans; D037102:Lectins; D011480:Protease Inhibitors; D011506:Proteins; D014361:Trypsin Inhibitors; D014107:Tosyllysine Chloromethyl Ketone; D014108:Tosylphenylalanyl Chloromethyl Ketone; D010958:Plasminogen; D000242:Cyclic AMP; D010447:Peptide Hydrolases; D013917:Thrombin; D006152:Cyclic GMP; D005947:Glucose